Neuromyelitis Optica Treatment

Authors:

Abstract
Neuromyelitis optica (NMO) (Devic disease) is an inflammatory autoimmune disease of the central nervous system that affects preferentially the optic nerve and spinal cord,1 distinct from multiple sclerosis (MS). Pathological study results obtained from patients with NMO have shown inflammation with macrophage predominance, perivascular granulocytes, eosinophils, immunoglobulin deposition, extensive axonal loss within the spinal cord, and optic nerve lesions.2 The recent identification of a specific antibody targeted to the blood-brain barrier water channel aquaporin 4 in patients with NMO (NMO-IgG) has turned it into a central nervous system autoimmune chanellopathy.3,4

This publication has 27 references indexed in Scilit: